PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0527/2021: EMA decision of 3 December 2021 on the acceptance of a modification of an agreed paediatric investigation plan for ruxolitinib (phosphate) (Jakavi), (EMEA-000901-PIP04-17-M02)